Sonnet BioTherapeutics: Pioneering Future Healthcare with Innovative Biologic Drug Development
Sonnet BioTherapeutics Holdings Inc. is a clinical-stage biotech company pioneering fully human albumin binding technology to develop targeted biologic drugs, potentially transforming treatment paradigms and redefining possibilities within healthcare.
- Sonnet BioTherapeutics Holdings Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read